Hypoxia-Inducible Protein 2 ( HIG2 ), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy

2006 ◽  
Vol 175 (4) ◽  
pp. 1272-1272
Author(s):  
A. Togashi ◽  
T. Katagiri ◽  
S. Ashida ◽  
T. Fujioka ◽  
O. Maruyama ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Diagnostic Marker ◽  
Molecular Therapy ◽  
Potential Target ◽  
Inducible Protein

Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy

2005 ◽  
Vol 65 (11) ◽  
pp. 4817-4826 ◽  
Author(s):  
Akira Togashi ◽  
Toyomasa Katagiri ◽  
Shingo Ashida ◽  
Tomoaki Fujioka ◽  
Osamu Maruyama ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Diagnostic Marker ◽  
Molecular Therapy ◽  
Potential Target ◽  
Inducible Protein

scholarly journals Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus

2018 ◽  
Vol Volume 11 ◽  
pp. 1997-2005 ◽  
Author(s):  
Cheng Peng ◽  
Liangyou Gu ◽  
Lei Wang ◽  
Qingbo Huang ◽  
Baojun Wang ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Inferior Vena Cava ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Vena Cava ◽  
Molecular Therapy ◽  
Targeted Molecular Therapy

Interferons Can Upregulate the Expression of the Tumor Associated Antigen G250-MN/CA IX, a Potential Target for (Radio)Immunotherapy of Renal Cell Carcinoma

2003 ◽  
Vol 18 (4) ◽  
pp. 539-547 ◽  
Author(s):  
Adrienne H. Brouwers ◽  
Cathelijne Frielink ◽  
Egbert Oosterwijk ◽  
Wim J.G. Oyen ◽  
Frans H.M. Corstens ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Potential Target ◽  
Ca Ix ◽  
Tumor Associated Antigen

Expression of the 5T4 Oncofoetal Antigen in Renal Cell Carcinoma: A Potential Target for T-Cell Based Immunotherapy

2005 ◽  
Vol 28 (6) ◽  
pp. 613
Author(s):  
Richard W Griffiths ◽  
Adam Dangoor ◽  
David E Gilham ◽  
Vijay Ramani ◽  
Noel Clarke ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
T Cell ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Potential Target ◽  
5T4 Oncofoetal Antigen

scholarly journals Robust response to nivolumab in patient with renal cell carcinoma inferior vena cava tumour thrombus

2019 ◽  
Vol 12 (4) ◽  
pp. e227030 ◽  
Author(s):  
Joel Berends ◽  
Eric Gourley ◽  
Dharam Kaushik
Keyword(s):  
Renal Cell Carcinoma ◽  
Inferior Vena Cava ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Inferior Vena ◽  
Vena Cava ◽  
Distant Metastases ◽  
Molecular Therapy ◽  
Tumour Thrombus ◽  
Robust Response

A 47-year-old previously healthy man presented with acute moderate flank pain. Evaluation revealed left renal cell carcinoma, with inferior vena cava tumour thrombus invasion. Patient had no significant history or risk factors to pre-dispose him to genitourinary cancers. Surgery was deemed to not be appropriate due to distant metastases, but patient received targeted molecular therapy and immunotherapy with striking regression of the thrombus.

Decreased Acetylation of Histone H3 in Renal Cell Carcinoma: A Potential Target of Histone Deacetylase Inhibitors

2008 ◽  
Vol 180 (3) ◽  
pp. 1131-1136 ◽  
Author(s):  
Kent Kanao ◽  
Shuji Mikami ◽  
Ryuichi Mizuno ◽  
Toshiaki Shinojima ◽  
Masaru Murai ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Histone Deacetylase ◽  
Renal Cell ◽  
Histone Deacetylase Inhibitors ◽  
Histone H3 ◽  
Potential Target

scholarly journals Expression of hypoxia-inducible protein 2 in renal cell carcinoma: A promising candidate for molecular targeting therapy

2010 ◽  
Vol 1 (4) ◽  
pp. 697-701 ◽  
Author(s):  
TAKASHI SEO ◽  
RYUICHIRO KONDA ◽  
JUN SUGIMURA ◽  
KAZUHIRO IWASAKI ◽  
YUSUKE NAKAMURA ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Molecular Targeting ◽  
Promising Candidate ◽  
Targeting Therapy ◽  
Molecular Targeting Therapy ◽  
Inducible Protein
Sign in / Sign up

Export Citation Format

Share Document